The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksMediumUpdated×2•Originally published 5 May 2026•Updated 5 May 2026•

1 min read

Fresenius Medical Care Posts 4% Organic Growth Despite Currency Headwinds in Q1

Key Facts

1Fresenius Medical Care revenue fell 6% in the first quarter of 2026.

2Financial results were weighed down by currency effects from a weak U.S. dollar and recent divestitures.

Updated financial data for Fresenius Medical Care reveals a 4% organic revenue growth in the first quarter of 2026, driven by expansion across all operating segments despite currency-related revenue declines. Operating income grew by 10%, successfully expanding the company's margin to 10.1%. Earnings per share (EPS) saw a significant 16% increase, bolstered by the strategic share buyback program. While the company continues its U.S. network restructuring with 64 clinic closures, management has officially confirmed its financial outlook for the full fiscal year 2026. These results highlight strong underlying performance and operational efficiency even as the firm navigates divestitures and macroeconomic volatility.

30 days ago

Version History

1 additional source confirmed this story

Version 230 days ago

What changed: Updated headline and body to reflect 4% organic growth, a 10% rise in operating income, a 16% jump in EPS, and the confirmation of full-year 2026 guidance.

Version 130 days ago

What changed: The story was updated to include specific details on the closure of 64 U.S. clinics and the impact of one-off restructuring costs on net profit.